Monday, November 9, 2026

USD/CNH Slides By 5% In The Last 21 Sessions

USD/CNH Slides By 5% In The Last 21 Sessions

(VIANEWS) - USD/CNH (USDCNH) has been up by 5.57% for the last 21 sessions. At 18:06 EST on Sunday, 26 March, USD/CNH (USDCNH) is $6.87.

USD/CNH's yearly highs and lows, it's 0.048% up from its 52-week low and 0.019% down from its 52-week high.

News about

  • Eur/usd edges lower, and tests 1.0750 support as a triple bottom stays in play. According to FXStreet on Saturday, 25 March, "The EUR/USD failed to hold to its previous gains, though the triple bottom chart pattern remains in play as long as it stays above 1.0759. "
  • According to FXStreet on Saturday, 25 March, "We have highlighted one supportive factor for EUR/USD as being the relative resilience of euro-zone banks compared to the US highlighted by the outperformance of the Euro Stoxx 600 Bank Index which is currently around unchanged on a year-to-date basis compared to more than a 20% drop for the S&P 500 equivalent.", "If confidence in European banks continues to deteriorate it seems highly likely that the correction lower in EUR/USD could have further to go. "
  • Eur/usd: seen at 1.05 in three months – rabobank. According to FXStreet on Saturday, 25 March, "In view of prevailing tensions we have not at this time revised our forecast of a dip in EUR/USD to 1.05 on a 3 month view, although we are clearly watching events carefully. ", "Analyst at Rabobank maintain their one and three month forecasts for the EUR/USD pair at 1.06 and 1.05 respectively, but they tweaked their six and 12-month forecast, pushing them slightly higher."
  • Eur/usd to reach 1.13 by end-2023 – wells fargo. According to FXStreet on Friday, 24 March, "But an extended period of US Dollar depreciation is fast approaching, wchi should lift EUR/USD to 1.13 by the end of the year, economists at Wells Fargo report.", "After the period of brief greenback stability in early 2023, we think the prospects for the Euro will brighten, and expect the EUR/USD exchange rate to reach 1.13 by the end of this year."
  • Eur/usd price analysis: bears flirt with golden fibonacci ratio, focus on 1.0765-60. According to FXStreet on Friday, 24 March, "It should be noted that the RSI's U-turn from the overbought territory breaks short-term support and the MACD also teases bears, which in turn suggests the EUR/USD pair's further downside even if the 61.8% Fibonacci retracement of February-March fall prods sellers of late.", "Alternatively, the EUR/USD pair's recovery moves may initially aim for the support-turned-resistance line stretched from Monday, near 1.0885 at the latest."

More news about USD/CNH (USDCNH).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com